While riding high on the popularity of its weight loss drug Zepbound, the company is quietly building a presence in a cutting ...

Novo Nordisk A/S shocked investors by forecasting a steep decline in sales this year, a sign of how intensifying price wars ...

Wauwatosa police said one person was taken into custody, and FOX6 News at the scene found a squad car had visible crash ...

The pharmaceutical giant (PFE) said two doses from a Phase 2b study of the once-a-month injection demonstrated weight reduction of 10% and 12.3% after 28 weeks in adults with obesity or overweight ...

Novo, which makes Ozempic and Wegovy, said it expected sales to fall by between 5% and 13% this year compared with growth of ...

Novo Nordisk stock (NVO) plunged approximately 15% after the Danish pharmaceutical giant posted better-than-expected 2025 results but delivered a weak 2026 outlook. The company reported full-year 2025 ...

The U.S. stock market is drifting through mixed trading, while gold and silver bounce back from their latest sell-off.

Novo Nordisk's stock plummets over 13% after the company warns of potential sales and profit declines in 2026, facing increasing competition in the weight-loss market, particularly from Eli Lilly's ...

COPENHAGEN, Feb 3 () - Wegovy maker Novo Nordisk warned on Tuesday that profits and sales could drop as much as 13% this year ...

Retail giant Walmart, which this week welcomed a new CEO, surpassed $1 trillion in market capitalization Tuesday as its shares surged.

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...

Eli Lilly plans to build a $3.5 billion pharmaceutical plant in Upper Macungie Township, for its next-generation weight-loss ...